Concepedia

Xiaobing Li

XL

Statistics

Publications

2

Citations

42

H-Index

2

Active since

2006

Affiliations

China Pharmaceutical University(Current)

Xiaobing Li is an author at China Pharmaceutical University specializing in oncology, oncology pharmacology, and cancer pharmacology.

ORCID

Publications per year

2006–2024

2

Publications

2

Effect of stealthy liposomal topotecan plus amlodipine on the multidrug‐resistant leukaemia cells <i>in vitro</i> and xenograft in mice

Xiaobing Li, Wei Lu, Gong‐Wen Liang et al. · European Journal of Clinical Investigation · 2006 · 31 citations

, , +17

The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study

Xiaobing Li, De Pei Wu, Jing Tang et al. · Cancer Management and Research · 2024 · 11 citations · Full text

, , +15

1–2 of 2